Related Experiment Video
Updated: Jan 23, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Neonatal Therapeutics: Considerations for Dosing
Kanecia O Zimmerman1,2, Daniel K Benjamin1,2, Mara L Becker1,2
1Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Insights
Neonates require special drug dosing due to immature physiology. Further research is crucial for safe and effective neonatal therapeutics.
Area of Science:
- Neonatal pharmacology and physiology
- Pediatric drug development
Background:
- Neonates are a vulnerable population with immature physiology, increasing risks during critical illness.
- Neonates frequently receive medications lacking sufficient safety, efficacy, and dosing data for this age group.
Purpose of the Study:
- To highlight the importance of understanding physiological differences in neonates for optimal drug dosing.
- To emphasize the need for dedicated pharmacokinetic and pharmacodynamic studies in neonates.
Main Methods:
- Review of physiological differences impacting drug disposition in neonates.
- Discussion of the necessity for targeted pharmacokinetic (PK) and pharmacodynamic (PD) studies.
Main Results:
- Physiological immaturity significantly alters drug absorption, distribution, metabolism, and excretion in neonates.
- Existing drug data is often inadequate for safe and effective neonatal use.
Conclusions:
- Understanding neonatal physiology is essential for appropriate therapeutic agent dosing.
- Well-designed PK/PD studies are critical for developing safe and effective neonatal therapeutics.
Abstract:
Neonates are a uniquely vulnerable population, compromised by immature physiology and critical illness if born premature. Furthermore, neonates have frequent exposures to drugs that lack adequate data on safety, efficacy, and appropriate dosing in this population. Key physiologic differences between neonates and older children and adults affect drug absorption, distribution, metabolism, and elimination. Adequate understanding and consideration of these differences is essential to ensure optimal dosing of therapeutic agents in this vulnerable population. Moreover, direct study of neonates through appropriately designed pharmacokinetic and pharmacodynamic studies can ensure the development of safe and effective therapeutics in our youngest populations of patients.
Related Concept Videos
Design Consideration
The factor of safety is another key...
Dose Size and Dosing Frequency: Determination Methods
Tensile Strength Considerations of Concrete
The dimensions and shape of a concrete specimen...
Transmission Line Design Considerations
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...

